These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7994590)

  • 1. Computer model challenges breast cancer treatment strategy.
    Retsky MW; Swartzendruber DE; Bame PD; Wardwell RH
    Cancer Invest; 1994; 12(6):559-67. PubMed ID: 7994590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective computerized simulation of breast cancer: comparison of computer predictions with nine sets of biological and clinical data.
    Retsky MW; Wardwell RH; Swartzendruber DE; Headley DL
    Cancer Res; 1987 Sep; 47(18):4982-7. PubMed ID: 2441859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Gompertzian or exponential kinetics a valid description of individual human cancer growth?
    Retsky MW; Swartzendruber DE; Wardwell RH; Bame PD
    Med Hypotheses; 1990 Oct; 33(2):95-106. PubMed ID: 2259298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative approach for treatment of breast cancer.
    Swartzendruber DE; Retsky MW; Wardwell RH; Bame PD
    Breast Cancer Res Treat; 1994; 32(3):319-25. PubMed ID: 7865858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standard chemotherapy for metastatic breast cancer].
    Tashiro H
    Nihon Rinsho; 2000 Apr; 58 Suppl():246-53. PubMed ID: 11026002
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of mitoxantrone in the treatment of breast cancer.
    Hainsworth JD
    Semin Oncol; 1995 Feb; 22(1 Suppl 1):17-20. PubMed ID: 7863347
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High-dose chemotherapy for metastatic breast cancer without certain advantages so far].
    Kleeberg UR
    Strahlenther Onkol; 2000 Jul; 176(7):334-5. PubMed ID: 10963001
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.
    Colleoni M; Price K; Castiglione-Gertsch M; Goldhirsch A; Coates A; Lindtner J; Collins J; Gelber RD; Thürlimann B; Rudenstam CM
    Eur J Cancer; 1998 Oct; 34(11):1693-700. PubMed ID: 9893654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benefits of adjuvant chemotherapy for breast cancer].
    Motomura K; Noguchi S; Inaji H; Koyama H
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1239-44. PubMed ID: 9279342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
    Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC
    J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adjuvant chemotherapy in male breast cancer.
    Patel HZ; Buzdar AU; Hortobagyi GN
    Cancer; 1989 Oct; 64(8):1583-5. PubMed ID: 2676137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose intensity in chemotherapy of metastatic breast cancer.
    J Clin Oncol; 1985 Jun; 3(6):889-91. PubMed ID: 3891924
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetic concepts in the treatment of breast cancer.
    Surbone A; Norton L
    Ann N Y Acad Sci; 1993 Nov; 698():48-62. PubMed ID: 8279784
    [No Abstract]   [Full Text] [Related]  

  • 15. Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy.
    Promberger R; Dubsky P; Mittlböck M; Ott J; Singer C; Seemann R; Exner R; Panhofer P; Steger G; Bergen E; Gnant M; Jakesz R; Bago-Horvath Z; Rudas M; Bartsch R
    Clin Breast Cancer; 2015 Dec; 15(6):505-11. PubMed ID: 26195436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative chemotherapy after failure of high-dose chemotherapy in breast cancer--toxicity and efficacy.
    Schrama JG; de Boer MM; Baars JW; Schornagel JH; Rodenhuis S
    Anticancer Res; 2003; 23(3C):2795-800. PubMed ID: 12926115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
    Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study.
    Ackland SP; Anton A; Breitbach GP; Colajori E; Tursi JM; Delfino C; Efremidis A; Ezzat A; Fittipaldo A; Kolaric K; Lopez M; Viaro D;
    J Clin Oncol; 2001 Feb; 19(4):943-53. PubMed ID: 11181656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for breast cancer brain metastases.
    Fenner MH; Possinger K
    Onkologie; 2002 Oct; 25(5):474-9. PubMed ID: 12415203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.
    Clahsen PC; van de Velde CJ; Julien JP; Floiras JL; Delozier T; Mignolet FY; Sahmoud TM
    J Clin Oncol; 1996 Mar; 14(3):745-53. PubMed ID: 8622020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.